Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aminosyn-PF (Pediatric Formula) is a sterile, non-pyrogenic intravenous amino acid solution specifically formulated for the nutritional support of neonates and pediatric patients requiring parenteral nutrition. Developed to mimic the plasma amino acid profile of healthy, breast-fed infants, the solution facilitates positive nitrogen balance and supports normal growth and development in infants, including those with low birth weight. The formulation is characterized by relatively high concentrations of taurine and low concentrations of methionine, phenylalanine, and glycine to accommodate the immature metabolic pathways of the liver in infants. It is typically administered as part of a total parenteral nutrition (TPN) regimen along with dextrose, electrolytes, and vitamins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aminosyn-PF.